Home » Real-world patient characteristics and survival outcomes of lenalidomide-refractory vs. lenalidomide-exposed RRMM patients in the HONEUR federated data network
Real-world patient characteristics and survival outcomes of lenalidomide-refractory vs. lenalidomide-exposed RRMM patients in the HONEUR federated data network - TriNetX
Real-world patient characteristics and survival outcomes of lenalidomide-refractory vs. lenalidomide-exposed RRMM patients in the HONEUR federated data network
